NHS Blood and Transport selects Amperia RED for at-line AAV Vector titre analysis to drive efficiencies in process development

In this application note, Abselion presents a study carried out at the Clinical Biotechnology Centre (CBC), Bristol. In need of a rapid but accurate viral vector quantification solution, the team undertook an assessment of the Amperia™ system to compare performance with the established automated ELISA method.